Abstract
Understanding the basis of variability in the response of patients to the dose of a drug and a willingness to vary the dose regimen as well as the choice of drug should be one of the key pillars of precision medicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Better governance starts with better words: why responsible human tissue research demands a change of language
BMC Medical Ethics Open Access 01 September 2022
-
Personalized Integrated Network Modeling of the Cancer Proteome Atlas
Scientific Reports Open Access 08 October 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bel, E. H. et al. Oral glucocorticoid sparing effect of mepolizumab in eosinophilic asthma. N. Engl. J. Med. 371, 1189–1197 (2014).
Yang, J. et al. The combination of exposure-response and case-control analyses in regulatory decision making. J. Clin. Pharmacol. 52, 160–166 (2012).
Wang, J. et al. Exposure–response relationship of T-DM1: insight into dose optimization for patients with HER2-positive metastatic breast cancer. Clin. Pharm. Ther. 95, 558–564 (2014).
Ohtsu, A. et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized double-blind, placebo-controlled phase III study. J. Clin. Oncol. 29, 3968–3976 (2011).
Grahnen, A. & Karlsson, M. O. Concentration-controlled or effect-controlled clinical trials. Useful alternatives to conventional dose-controlled trials? Clin. Pharmacokinet. 40, 317–325 (2001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.W.P. is an employee of F. Hoffman la Roche. He holds stock and options in F. Hoffman la Roche and stock in Eli Lilly and Company Ltd.
Rights and permissions
About this article
Cite this article
Peck, R. The right dose for every patient: a key step for precision medicine. Nat Rev Drug Discov 15, 145–146 (2016). https://doi.org/10.1038/nrd.2015.22
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2015.22
This article is cited by
-
Characterization of behavioral changes in T-maze alternation from dopamine D1 agonists with different receptor coupling mechanisms
Psychopharmacology (2023)
-
Better governance starts with better words: why responsible human tissue research demands a change of language
BMC Medical Ethics (2022)
-
Personalized Integrated Network Modeling of the Cancer Proteome Atlas
Scientific Reports (2018)
-
CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure
Pharmaceutical Research (2017)